Inpharma logo Adis International logo

Publisher: Adis International

Volume 1, Number 1592, 2007-06-16
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Research article

Sublingual misoprostol compared with vaginal misoprostol for medical abortion
pp. 1-1(1)

Short communication

Cold remedies and crystal meth: the debate over ephedrine
pp. 2-2(1)

Public & private health systems: on the same (balance) sheet?
pp. 3-3(1)

Stockpiling of candidate vaccine best bet for future flu pandemic
pp. 3-3(1)

UK NICE has recommended the use of varenicline as a treatment option for adults with a desire to quit smoking.
pp. 3-3(1)

UK NICE has recommended a scheme which would make bortezomib more accessible to UK NHS patients with multiple myeloma
pp. 3-3(1)

Research article

Unconditional statin treatment dominant for diabetics
pp. 4-4(1)

Tacrolimus tops steroids for atopic dermatitis
pp. 4-4(1)

Short communication

Paclitaxel poliglumex produces cost savings in NSCLC
pp. 4-4(1)

News from ATC
pp. 5-5(1)

Research article

Which treatment option best value in paediatric empyema?
pp. 5-5(1)

Atypical antipsychotics elevate costs in schizophrenia
pp. 5-5(1)

Short communication

R&D news from ASCO
pp. 6-6(1)

EVT 201, a partial positive allosteric modulator of the GABAA receptor complex, shows promise in patients with insomnia
pp. 6-6(1)

An intranasal formulation of ketorolac [ROX 888] provides effective pain relief after surgery
pp. 6-6(1)

Mymetics Corporation's HIV vaccine has demonstrated the first-ever stimulation of neutralising IgA antibodies in nonhuman primates
pp. 6-6(1)

CDB-4124 reduces both the duration and intensity of pain associated with endometriosis
pp. 6-6(1)

Research article

Sorafenib looking SHARP in advanced HCC
pp. 7-8(2)

Short communication

Encouraging results with enclomifene in hypogonadism
pp. 8-8(1)

Dimebolin is beneficial in Alzheimer's disease
pp. 8-8(1)

Eltrombopag is an effective therapy for patients with chronic idiopathic thrombocytopenic purpura
pp. 8-8(1)

News from AHS
pp. 9-9(1)

Research article

Omega-3 fatty acid supplementation may be an effective adjuvant therapy for patients with inflammatory joint pain
pp. 9-9(1)

Short communication

The addition of tocilizumab [Actemra] to a disease-modifying antirheumatic drug (DMARD) regimen improves rheumatoid arthritis
pp. 9-9(1)

FP 0011, a glutamate release inhibitor, improves Parkinsonian symptoms
pp. 9-9(1)

KB 2115, a first-in-class liver-selective thyroid hormone receptor agonist, shows promise in the treatment of lipid metabolism disorders
pp. 9-9(1)

Research article

Sinapultide SELECTed for gold STAR in preventing RDS
pp. 10-10(1)

Imidapril as effective as candesartan cilexetil for hypertension
pp. 10-10(1)

Rituximab plus chemotherapy is superior to chemotherapy alone in patients with indolent or mantle cell lymphoma
pp. 10-10(1)

The addition of lactoferrin and probiotics to standard triple therapy may be beneficial in patients with Helicobacter pylori infections
pp. 10-10(1)

Ziprasidone has similar effects on schizophrenic patients in a naturalistic setting as in more restricted clinical trials
pp. 11-11(1)

Prolonged warfarin use reduces the incidence of prostate cancer for men aged ≥ 50 years
pp. 11-11(1)

Hydrochlorothiazide + amiloride for stable exertional angina
pp. 11-11(1)

Short communication

Chromium/biotin beneficial in overweight patients with T2DM
pp. 11-11(1)

Tenofovir comparable to adefovir for chronic hep B
pp. 11-11(1)

Therapy news from the American Society of Clinical Oncology
pp. 12-13(2)

Research article

Low-dose botulinum toxin A is effective for pain relief in patients with piriformis syndrome
pp. 13-13(1)

A combination of cisplatin, etoposide and slow-release lanreotide is effective for the treatment of patients with metastatic endocrine tumours
pp. 13-13(1)

Short communication

The number of pills a patient is prescribed appears to have no major effect on their daily adherence to medication
pp. 13-13(1)

Reduction of cancer risk with vitamin D3 brought to light
pp. 13-13(1)

Research article

Considerable reductions in US coronary deaths - why?
pp. 14-14(1)

Stepped buprenorphine strategy equals conventional methadone
pp. 14-14(1)

Pioglitazone enhances flutamide plus metformin therapy in women with hyperinsulinaemic hyperandrogenism
pp. 14-14(1)

Short communication

Alcohol dulls the pain
pp. 14-14(1)

Research article

Cetuximab an EXTREMEly important addition in SCCHN
pp. 15-15(1)

Preoperative trastuzumab, docetaxel and carboplatin therapy is effective for HER2-positive breast cancer
pp. 16-16(1)

Short communication

Adjuvant mitotane shows benefits in adrenocortical carcinoma
pp. 16-16(1)

Research article

Weekly cladribine treatment is comparable to daily treatment in active hairy cell leukaemia
pp. 16-16(1)

Peginterferon vs interferon for hep C: more effective but more risk
pp. 16-16(1)

Zoledronic acid is an effective preventative or treatment of bone loss in men with HIV infections receiving HAART
pp. 16-16(1)

Guanfacine XR excels in ADHD
pp. 17-18(2)

Aerosolised tobramycin effective in CF P. aeruginosa infection
pp. 19-19(1)

Low-dose S 1 plus irinotecan shows potential as a regimen with minimal toxicity in advanced colorectal cancer
pp. 19-19(1)

Oral budesonide is effective in patients with chronic pouchitis resistant to standard antibiotic treatment
pp. 19-19(1)

Adalimumab for psoriatic arthritis unresponsive to DMARDs
pp. 19-19(1)

Immunisations greatly decrease the risk of sudden infant death syndrome
pp. 20-20(1)

Coadministration of etoricoxib and warfarin is unlikely to result in clinically important interactions
pp. 20-20(1)

Prolonged topotecan therapy is beneficial in patients with recurrent ovarian cancer resistant to platinum-based chemotherapy
pp. 20-20(1)

Ketorolac is an effective prophylactic analgesic for patients undergoing retinal detachment surgery
pp. 20-20(1)

Sildenafil improves sperm motility but may have adverse effects on male fertility
pp. 20-20(1)

A histrelin subdermal implant is effective in children with central precocious puberty
pp. 20-20(1)

Short communication

FDA halts canfosfamide trials
pp. 21-21(1)

Research article

Ranitidine elevates risk of neonatal late-onset sepsis
pp. 21-21(1)

Short communication

Haloperidol as a first-line delirium treatment "will not contribute to the establishment of drug therapy for delirium based on risk-benefit assessment"
pp. 21-21(1)

Research article

Non-trial duloxetine poorly tolerated
pp. 21-21(1)

Review article

Statins "safe" in standard doses
pp. 22-22(1)

Short communication

Product launches in Japan
pp. 22-22(1)

EU product approvals
pp. 22-22(1)

US product approvals
pp. 22-22(1)

Other US regulatory news
pp. 23-23(1)

Bristol-Myers Squibb has launched abatacept [Orencia] in the UK for moderate to severe rheumatoid arthritis
pp. 23-23(1)

Health Canada has expanded the indication for clopidogrel [Plavix; sanofi-aventis, Bristol-Myers Squibb] to include patients with all acute coronary syndromes
pp. 23-23(1)

Mallinckrodt Brand Pharmaceuticals' oxycodone/paracetamol [oxycodone/acetaminophen; Magnacet] has been launched in the US
pp. 23-23(1)

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A